adalimumab place in therapy — Main — tl;dr pharmacy

Posts tagged adalimumab place in therapy

New FDA Approval: Amjevita

New FDA Approval: Amjevita

Drug

Adalimumab-atto [Amjevita]

Indication

Amjevita is a biosimilar to adalimumab [Humira], so it has the same indications. It's used in inflammatory conditions mediated by the immune system

FDA Approval, Clinical, Pharmacy School, PracticeBrandon DysonOctober 10, 2016Amjevita, adalimumab, biosimilar, amjevita place in therapy, adalimumab place in therapy